Clinical Trials for Camptosar (Irinotecan)

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentCOGACNS0821
10/08/2011
ACNS0821 - Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.